These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3114881

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fibrin-specific thrombolytic agents.
    Collen D.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H, Kasai S, Nishida M, Suyama T.
    Rinsho Byori; 1989 Apr 14; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract] [Full Text] [Related]

  • 30. [Streptokinase or urokinase: the elements of choice].
    Pâques EP.
    Haemostasis; 1986 Apr 14; 16 Suppl 4():21-5. PubMed ID: 2429902
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S, Margheri F, Bruschi S, D'Alessio S, Pucci M, Fibbi G, Tonelli P, Del Rosso M.
    Eur J Oral Sci; 2006 Dec 14; 114(6):500-3. PubMed ID: 17184232
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo].
    Melandri G, Branzi A, Berardi C, Bruscoli F, Tartagni F, Binetti G, Galiè N, Magnani B, Gensini GF, Abbate R.
    Cardiologia; 1987 Jul 14; 32(7):619-26. PubMed ID: 3319156
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Initial experiences with pro-urokinase in acute myocardial infarct].
    Schanzenbächer P, Huber J, Keller F, Kochsiek K.
    Z Kardiol; 1987 Sep 14; 76(9):570-5. PubMed ID: 3122430
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.